View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration...

Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts Global pivotal Phase 3 clinical trial would be conducted jointly by Verrica and Torii Pharmaceutical; trial expected to begin in the 1st half of 2025 Amendment should benefit both parties from a cost and time to market standpoint; funding structure is expected to have a minimal impact on Verrica’s cash position Common warts is one of the largest and most underserved p...

 PRESS RELEASE

CNB Financial Corporation Announces Quarterly Dividend for Common Stoc...

CNB Financial Corporation Announces Quarterly Dividend for Common Stock CLEARFIELD, Pa., May 14, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of CNB Financial Corporation (Nasdaq: CCNE) declared a quarterly cash dividend of $0.175 per share of common stock payable on June 14, 2024 to common stock shareholders of record as of May 31, 2024. CNB Financial Corporation is a financial holding company with consolidated assets of approximately $5.8 billion. CNB Financial Corporation conducts business primarily through its principal subsidiary, CNB Bank. CNB Bank is a full-service bank engagin...

 PRESS RELEASE

Avis Budget Group Announces Pricing of €200 Million of Senior Notes

Avis Budget Group Announces Pricing of €200 Million of Senior Notes PARSIPPANY, N.J., May 14, 2024 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) (the “Company”) announced today that its wholly-owned subsidiary, Avis Budget Finance plc (the “Issuer”), priced a private offering of €200 million aggregate principal amount of additional 7.25% Senior Notes due 2030 (the “Notes”). The Notes will be issued as additional notes under the Indenture, dated as of July 13, 2023, pursuant to which the Issuer previously issued €400 million aggregate principal amount of 7.25% Senior Notes due...

 PRESS RELEASE

Eyenovia to Report First Quarter 2024 Results on Wednesday, May 15th

Eyenovia to Report First Quarter 2024 Results on Wednesday, May 15th Company to host an investor conference call and webcast at 4:30pm EDT NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: EYEN), an ophthalmic company with two FDA-approved products and a late-stage asset in pediatric progressive myopia, today announced that the Company will release financial results for the first quarter ended March 31, 2024 on Wednesday, May 15th, 2024, after the markets close. Following the release, Eyenovia management will host a conference call and webcast at 4:30 p.m. ET to review the financial ...

 PRESS RELEASE

Black Hills Corp. Announces Pricing of $450 Million Debt Offering

Black Hills Corp. Announces Pricing of $450 Million Debt Offering RAPID CITY, S.D., May 13, 2024 (GLOBE NEWSWIRE) -- Black Hills Corp. (NYSE: BKH) today announced the pricing of a registered public debt offering of $450 million aggregate principal amount of 6.00% senior unsecured notes due Jan. 15, 2035. The company expects the offering to close on May 16, 2024, subject to customary closing conditions. The company plans to use the net proceeds from the offering, together with available cash or short-term borrowings under its existing facilities, to repay its $600 million principal amount...

 PRESS RELEASE

Verrica Pharmaceuticals Reports First Quarter 2024 Financial Results

Verrica Pharmaceuticals Reports First Quarter 2024 Financial Results – Reports YCANTH® revenue of $3.2M for first quarter of 2024 – – Over 228 million lives now covered to date on commercial insurance, managed Medicaid, Tricare and Federal Employee plans – – Preliminary Phase 2 results for VP-315 in the treatment of basal cell carcinoma (BCC) expected in the second quarter of 2024 – – Conference Call Scheduled for Today at 8:30 am ET – WEST CHESTER, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company develop...

 PRESS RELEASE

Avis Budget Group Announces Intention to Offer €200 Million of Senior ...

Avis Budget Group Announces Intention to Offer €200 Million of Senior Notes PARSIPPANY, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) (the “Company”) announced today that its wholly-owned subsidiary, Avis Budget Finance plc (the “Issuer”), intends, subject to market and other customary conditions, to offer €200 million aggregate principal amount of additional 7.25% Senior Notes due 2030 (the “Notes”) in a private offering. The Notes will be issued as additional notes under the Indenture, dated as of July 13, 2023, pursuant to which the Issuer previously issu...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: May 11, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Occidental Petroleum Corporation: Key facts and statistics - 2023

A summary company profile, detailing Occidental Petroleum Corporation’s business operations and financial highlights.

 PRESS RELEASE

Cannae Holdings, Inc. Announces Quarterly Cash Dividend of $0.12

LAS VEGAS--(BUSINESS WIRE)-- Cannae Holdings, Inc. (NYSE: CNNE) (“Cannae” or the “Company”) today announced that its Board of Directors has declared a quarterly cash dividend of $0.12 per share. The dividend will be payable June 28, 2024, to shareholders of record as of June 14, 2024. About Cannae Holdings, Inc. We primarily acquire interests in operating companies and are actively engaged in managing and operating a core group of those companies. We believe that our long-term ownership and active involvement in the management and operations of companies helps maximize the value of those b...

 PRESS RELEASE

Cannae Holdings, Inc. Announces First Quarter 2024 Financial Results

LAS VEGAS--(BUSINESS WIRE)-- Cannae Holdings, Inc. (NYSE: CNNE) (“Cannae” or the “Company”) has released its first quarter 2024 financial results by posting them to its website. Please visit the Cannae website at to view the first quarter 2024 financial results, which are included in its Letter to Shareholders. Conference Call As previously announced, Cannae will host a conference call, today, May 9, 2024 at 5:00pm (Eastern Time), to discuss its first quarter 2024 results. The conference call can be accessed by dialing 1-844-826-3035 (domestic) or 1-412-317-5195 (international) and asking...

 PRESS RELEASE

Verrica Pharmaceuticals to Present at Upcoming Investor Conferences

Verrica Pharmaceuticals to Present at Upcoming Investor Conferences WEST CHESTER, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that Ted White, Verrica Pharmaceuticals’ President and Chief Executive Officer, will present at the following investor conferences: RBC Capital Markets Global Healthcare ConferenceDate: Wednesday, May 15, 2024Time: 3:05 p.m. ETLocation: New York, NY HCW BioConnect Conferenc...

Axis Capital Holdings Ltd: 1 director

A director at Axis Capital Holdings Ltd bought 3,025 shares at 66.580USD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...

 PRESS RELEASE

Atmos Energy Corporation Reports Earnings for Fiscal 2024 Second Quart...

DALLAS--(BUSINESS WIRE)-- Atmos Energy Corporation (NYSE: ATO) today reported consolidated results for its second fiscal quarter ended March 31, 2024. This news release should be read in conjunction with our Form 10-Q and earnings slides which are concurrently being posted at . Fiscal Year to Date Highlights Earnings per diluted share of $4.93 on net income of $743.3 million. Capital expenditures were $1,415.5 million; approximately 81 percent focused on safety and reliability. Strong financial profile with 60.9% equity capitalization and $4.2 billion in available liquidity. Impl...

 PRESS RELEASE

Atmos Energy Declares Regular Quarterly Dividend

DALLAS--(BUSINESS WIRE)-- Atmos Energy Corporation (NYSE: ATO) said today that its Board of Directors declared a quarterly dividend on the company’s common stock of 80.5 cents per share. The indicated annual dividend is $3.22. The dividend will be paid on June 10, 2024, to shareholders of record on May 28, 2024. This is the company’s 162nd consecutive quarterly dividend. Atmos Energy Corporation, an S&P 500 company headquartered in Dallas, is the country’s largest natural gas-only distributor. We safely deliver reliable, efficient and abundant natural gas to more than 3 million distributio...

 PRESS RELEASE

Black Hills Corp. Reports 2024 First-Quarter Results and Reaffirms 202...

Black Hills Corp. Reports 2024 First-Quarter Results and Reaffirms 2024 Earnings Guidance RAPID CITY, S.D., May 08, 2024 (GLOBE NEWSWIRE) -- Black Hills Corp. (NYSE: BKH) today announced financial results for the first quarter of 2024. Net income available for common stock and earnings per share for the three months ended March 31, 2024, compared to the three months ended March 31, 2023, were:  Three Months Ended March 31, 2024 2023 (in millions, except per share amounts)Net income available for common stock$127.9 $114.1Earnings per share, Diluted$1.87 $1.73       First quarter earnings w...

 PRESS RELEASE

Verrica Pharmaceuticals to Provide a Corporate Update and Report First...

Verrica Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 13, 2024 WEST CHESTER, Pa., May 08, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that it will host a conference call and live webcast at 8:30 a.m. ET on Monday, May 13, 2024 to provide a corporate update and discuss the Company's financial results for the first quarter ended March 31, 2024. Individuals ma...

 PRESS RELEASE

Occidental Announces First Quarter 2024 Results

Occidental Announces First Quarter 2024 Results HOUSTON, May 07, 2024 (GLOBE NEWSWIRE) -- (NYSE: OXY) today announced its first quarter 2024 financial results. The earnings release and accompanying financial schedules can be accessed via the section of the company’s website, . The earnings release is also available on the U.S. Securities and Exchange Commission’s website at sec.gov. The company will hold a conference call to discuss the results on Wednesday, May 8, 2024, at 1 p.m. Eastern/12 p.m. Central. The conference call may be accessed by calling 1-866-871-6512 (international call...

 PRESS RELEASE

Post Holdings Reports Results for the Second Quarter of Fiscal Year 20...

Post Holdings Reports Results for the Second Quarter of Fiscal Year 2024; Raises Fiscal Year 2024 Outlook ST. LOUIS, May 02, 2024 (GLOBE NEWSWIRE) -- Post Holdings, Inc. (NYSE:POST), a consumer packaged goods holding company, today reported results for the second fiscal quarter ended March 31, 2024. Highlights: Second quarter net sales of $2.0 billionOperating profit of $190.1 million; net earnings of $97.2 million and Adjusted EBITDA (non-GAAP)* of $345.2 millionRaised fiscal year 2024 Adjusted EBITDA (non-GAAP)* outlook to $1,335-$1,375 million *For additional information regarding n...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch